Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety thro… Read more
Xtant Medical Holdings Inc (XTNT) - Total Assets
Latest total assets as of September 2025: $106.32 Million USD
Based on the latest financial reports, Xtant Medical Holdings Inc (XTNT) holds total assets worth $106.32 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Xtant Medical Holdings Inc - Total Assets Trend (2008–2024)
This chart illustrates how Xtant Medical Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Xtant Medical Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Xtant Medical Holdings Inc's total assets of $106.32 Million consist of 71.5% current assets and 28.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.6% |
| Accounts Receivable | $20.66 Million | 22.0% |
| Inventory | $38.63 Million | 41.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $8.36 Million | 8.9% |
| Goodwill | $7.30 Million | 7.8% |
Asset Composition Trend (2008–2024)
This chart illustrates how Xtant Medical Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Xtant Medical Holdings Inc's current assets represent 71.5% of total assets in 2024, a decrease from 100.0% in 2008.
- Cash Position: Cash and equivalents constituted 6.6% of total assets in 2024, down from 31.3% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is inventory at 41.2% of total assets.
Xtant Medical Holdings Inc Competitors by Total Assets
Key competitors of Xtant Medical Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Xtant Medical Holdings Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Xtant Medical Holdings Inc generates 1.25x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Xtant Medical Holdings Inc is currently not profitable relative to its asset base.
Xtant Medical Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.21 | 2.12 | 1.22 |
| Quick Ratio | 1.06 | 0.88 | 0.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $42.83 Million | $ 37.74 Million | $ 5.72 Million |
Xtant Medical Holdings Inc - Advanced Valuation Insights
This section examines the relationship between Xtant Medical Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.62 |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | 1.3% |
| Total Assets | $93.84 Million |
| Market Capitalization | $27.29 Million USD |
Valuation Analysis
Below Book Valuation: The market values Xtant Medical Holdings Inc's assets below their book value (0.29 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Xtant Medical Holdings Inc's assets grew by 1.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Xtant Medical Holdings Inc (2008–2024)
The table below shows the annual total assets of Xtant Medical Holdings Inc from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $93.84 Million | +1.32% |
| 2023-12-31 | $92.61 Million | +53.77% |
| 2022-12-31 | $60.23 Million | +10.12% |
| 2021-12-31 | $54.69 Million | +31.90% |
| 2020-12-31 | $41.47 Million | -3.91% |
| 2019-12-31 | $43.16 Million | -7.04% |
| 2018-12-31 | $46.42 Million | -56.08% |
| 2017-12-31 | $105.70 Million | -26.65% |
| 2016-12-31 | $144.10 Million | +0.73% |
| 2015-12-31 | $143.06 Million | +411.82% |
| 2014-12-31 | $27.95 Million | -3.21% |
| 2013-12-31 | $28.88 Million | -16.29% |
| 2012-12-31 | $34.50 Million | +48.88% |
| 2011-12-31 | $23.17 Million | +46.98% |
| 2010-12-31 | $15.76 Million | +50.33% |
| 2009-12-31 | $10.49 Million | +7404.61% |
| 2008-12-31 | $139.73K | -- |